ALK Inhibitor in Metastatic Colorectal Cancer With ALK Mutation.
NCT03792568
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
OTHER:
ALK Inhibitor
Sponsor
Shanghai Changzheng Hospital